AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
WLK
ACCE-researched

Westlake Corporation Common Stock (WLK) fair value

Basic Materials · Specialty Chemicals · NYSE · United States
$64.56+0.65%
Market cap $8.3BNext earnings 2026-11-04Updated Oct 18, 2026
Add earnings to calendarGoogle
Our verdict
Trades 46% below our fair value
Price
$64.56
Model fair valueConfidence: low
about $121
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a loss-making company: Sales comps and Analyst consensus.
ACCE opinionWestlake Corporation Common Stock (WLK)
Fair value (2 models)
Not available
ACCE price target
$73.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 27 Sept 2026, 00:00 CEST.
Price used: $64.56 at the close on 23 Oct 2026, 22:00 CEST.
Models: Analyst consensus and Sales comps.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
34
out of 100
Analysts
35% buy
17 covering
1-year return
-18.1%
Dividend yield
3.32%

Westlake Corporation Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Westlake makes commodity petrochemicals and vinyls, including PVC resin, ethylene, caustic soda, and building products such as siding and decking, and its earnings track the cycle in these markets closely. Its main structural asset is cost position: it is a low-cost ethane-based producer in the US Gulf Coast, which should hold up better than naphtha-based competitors when feedstock and energy prices move against them. The near-term question is whether volumes recover in construction and housing, where demand for PVC pipe, siding and decking is tied to interest rates and new starts. Revenue grew 10.8%, but the company reports a negative 11.9% return on equity and a gross margin of only 10.2%, so the top line is not yet reaching shareholders. At a forward P/E of 22.1, the market is paying for a margin recovery that the trailing numbers do not yet show. The score of 34/100 and the absence of index membership suggest the quality screen is weak, so this merits a deeper look only if you have a view on the petrochemical cycle and the timing of a margin turn.

AI-assisted·How I use AIWritten Oct 14, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • high
    Earnings collapse
    YoY earnings down 62.3% despite 10.8% revenue growth. Net margin negative at -10.9% and ROE at -11.9% signal profitability breakdown.
  • high
    Insider selling pressure
    Last 10 disclosures show $3.12M in insider sales, zero buys. Insiders own 74.5% but are liquidating, not accumulating.
  • moderate
    Elevated short interest
    16.3% short interest paired with negative earnings and insider selling suggests skepticism about near-term recovery.
  • moderate
    Weak cash generation
    FCF of $23M on $8.0B market cap (0.3% yield) is thin. Debt/Equity 0.64 is manageable but leaves little margin for error.

AI research notes

AI-assisted·How I use AIWritten Oct 11, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Recent earnings beat expectations by 4.1%, suggesting operational momentum despite sector headwinds.
  • Year-over-year revenue grew 10.8%, indicating near-term demand strength in core markets.
  • Analyst consensus targets $85.63, implying 37.5% upside from current $62.29 price.
Why it could disappoint
  • Five-year revenue trend is negative 10.9% annually, showing structural decline in the business.
  • Net margin is negative 10.9% and ROE is negative 11.9%, destroying shareholder value currently.
  • Free cash flow yield of 0.3% on a 21.0x forward P/E leaves little margin for error.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where WLK's valuation models land
Price
$64.56
Model fair valueConfidence: low
about $121
Model
Fair value
Upside
Analyst consensus
Sales comps
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bearish35% buy · 17 covering analysts
● Strong buy 4● Buy 2● Hold 10● Sell 1● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+1.9%
1 month
-5.6%
3 months
-12.5%
6 months
-41.6%
YTD
-12.7%
1 year
-18.1%

SEC filings

Recent ACCE blog coverage

  • $WLK Score Jumps 16 Points to 37 on Westlake Turnaround Signs
    Westlake Corporation's ACCE score surged from 21 to 37, suggesting improving fundamentals in the chemical manufacturer despite recent revenue headwinds.
    2026-05-14

Recommendation history, last 12 months

DateTypeNewPreviousPrice
6 Oct 2026, 00:00 CESTFair value$77.41$78.32$63.50
4 Oct 2026, 00:00 CESTFair value$78.32$81.68$63.50
28 Sept 2026, 00:00 CESTFair value$81.68$84.11$67.71
27 Sept 2026, 00:00 CESTACCE price target$73.00first publication$67.71
25 Sept 2026, 00:00 CESTFair value$84.11$83.06$68.42
16 Sept 2026, 00:00 CESTFair value$83.06$84.60$68.96
14 Sept 2026, 00:00 CESTFair value$84.60$87.88$70.81
7 Sept 2026, 00:00 CESTFair value$87.88$89.21$74.79
31 Aug 2026, 00:00 CESTFair value$89.21$44.16$75.71
23 Aug 2026, 00:00 CESTFair value$44.16$43.18$79.35

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full WLK page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth40Value42Quality36Momentum17Total34
Valuation
Trailing P/E
no data
Forward P/E
25.7x
PEG
no data
P/B
1.01x
EV / Revenue
1.1x
Book value/sh
$68.12
Enterprise value
$12.8B
Profitability
ROE
-11.9%
FCF yield
-6.82%
ROIC
-8.1%
Health and risk
Debt / equity
0.73
Dividend yield
3.32%
Beta
0.69

Price

-18.5% · 1Y

Ask anything about WLK

Answered from Westlake Corporation Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 0% of peers
low -12%-12%high 13%
Div yieldbetter than 83% of peers
low 0.1%3.3%high 3.6%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
WLK Westlake Corporation Common Stock$64.56----11.9%3634
4188.T Mitsubishi Chemical Group Corporation¥1122.00---1.4%4775
BERGEPAINT.NS Berger Paints India Limited₹469.95--44.7x-7652
LINDEINDIA.NS Linde India Limited₹5900.50--89.3x-8944
FLUOROCHEM.NS Gujarat Fluorochemicals Limited₹4303.90--76.1x-8166
4183.T Mitsui Chemicals, Inc.¥2056.00--11.5x8.0%4764
6988.T Nitto Denko Corporation¥3709.00--18.3x12.5%6966

Sector report card

Where WLK ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 5, 2026
    Westlake Royal Building Products™ Consolidates US Tile® and Newpoint™ Roofing Brands Under One Name
  • GlobeNewswire•Oct 1, 2026
    Westlake Royal Building Products™ Enters Standing-Seam Roofing Market Through Purchase of Roofing Assets
  • GlobeNewswire•Sep 29, 2026
    Westlake to Optimize European Chlorovinyls Footprint with Closure of Cologne PVC Plant
9 more press releases · full archive on Investor+.INVESTOR
40 filings
September 2026
Sep 29
8-KCurrent reportPeriod 2026-09-24
View on SEC →
Sep 1
Form 4Insider transactionPeriod 2026-08-31
View on SEC →
August 2026
Aug 31
8-KCurrent reportPeriod 2026-08-31
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR